KPL-914-C002- A Phase 3, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study With Open-Label Extension, To Assess The Efficacy And Safety Of Rilonacept Treatment In Subjects With Recurrent Pericarditis. (RHAPSODY)

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/48510/MonH-2019-162416(v1)
NMA SSA Reference Number: SSA/48510/MonH-2019-162927(v1)
Monash Health Ref: RES-19-0000035A
StatusFinished
Effective start/end date3/06/19 → 2/06/24

Keywords

  • clinical trial
  • treatment efficacy
  • pericarditis

Clinical Trial Phase

  • Phase III (a & b)